Your browser is no longer supported. Please, upgrade your browser.
FLXN Flexion Therapeutics, Inc. daily Stock Chart
FLXN [NASD]
Flexion Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.79 Insider Own1.60% Shs Outstand38.55M Perf Week-9.58%
Market Cap563.53M Forward P/E- EPS next Y-1.60 Insider Trans1.33% Shs Float34.55M Perf Month0.93%
Income-145.00M PEG- EPS next Q-0.80 Inst Own78.00% Short Float25.20% Perf Quarter35.63%
Sales82.50M P/S6.83 EPS this Y12.50% Inst Trans-0.02% Short Ratio9.57 Perf Half Y-43.26%
Book/sh-1.36 P/B- EPS next Y43.30% ROA-64.50% Target Price21.89 Perf Year10.00%
Cash/sh2.66 P/C4.50 EPS next 5Y20.00% ROE- 52W Range5.01 - 22.98 Perf YTD-42.08%
Dividend- P/FCF- EPS past 5Y-14.90% ROI-78.50% 52W High-47.82% Beta2.09
Dividend %- Quick Ratio4.50 Sales past 5Y- Gross Margin87.30% 52W Low139.32% ATR0.74
Employees288 Current Ratio5.10 Sales Q/Q89.60% Oper. Margin- RSI (14)49.48 Volatility5.04% 6.25%
OptionableYes Debt/Eq- EPS Q/Q12.70% Profit Margin- Rel Volume0.35 Prev Close12.16
ShortableYes LT Debt/Eq- EarningsMay 07 AMC Payout- Avg Volume910.15K Price11.99
Recom1.80 SMA20-3.93% SMA505.73% SMA200-14.79% Volume315,809 Change-1.40%
Jun-25-20Initiated H.C. Wainwright Buy $25
May-27-20Initiated Guggenheim Buy $20
Dec-27-19Reiterated The Benchmark Company Buy $19 → $25
Dec-05-19Initiated Craig Hallum Buy
Nov-25-19Initiated BTIG Research Buy $27
May-09-19Upgrade The Benchmark Company Hold → Buy $19
Jan-04-19Reiterated Needham Buy $42 → $36
Jan-04-19Downgrade The Benchmark Company Buy → Hold
Jun-28-18Initiated The Benchmark Company Buy $39
Oct-09-17Reiterated Needham Buy $36 → $42
Aug-24-17Initiated Northland Capital Outperform
Dec-22-16Initiated Raymond James Strong Buy
Sep-06-16Resumed Lake Street Buy $38
Jul-21-16Initiated Lake Street Buy $38
May-03-16Resumed Wells Fargo Outperform
Nov-04-15Initiated Cantor Fitzgerald Buy
Sep-09-15Reiterated Needham Buy $31 → $28
May-14-15Initiated Northland Capital Outperform $40
Mar-31-15Initiated MLV & Co Buy $38
Aug-14-14Initiated Summer Street Research Buy $25
Jul-08-20 12:00PM  
Jul-02-20 08:30AM  
Jun-27-20 01:20PM  
Jun-25-20 10:10AM  
Jun-16-20 04:30PM  
Jun-11-20 05:36PM  
10:23AM  
May-28-20 09:13AM  
May-21-20 12:02PM  
07:30AM  
May-20-20 04:01PM  
May-14-20 09:27AM  
May-13-20 05:00PM  
May-09-20 03:00PM  
May-07-20 04:01PM  
May-05-20 09:00AM  
May-01-20 09:00AM  
Apr-30-20 04:30PM  
Apr-27-20 07:30AM  
Apr-07-20 04:30PM  
Apr-03-20 04:30PM  
Apr-01-20 07:00AM  
Mar-16-20 03:49PM  
Mar-14-20 08:55AM  
Mar-12-20 06:35PM  
04:01PM  
Mar-11-20 04:30PM  
Mar-06-20 04:30PM  
Mar-05-20 12:30PM  
Mar-04-20 04:30PM  
Feb-24-20 04:30PM  
Feb-20-20 12:31PM  
07:12AM  
Feb-07-20 04:30PM  
Jan-28-20 02:36PM  
01:48PM  
Jan-15-20 06:34AM  
Jan-13-20 08:30AM  
Jan-10-20 07:13AM  
Jan-09-20 04:01PM  
Jan-03-20 04:30PM  
Jan-01-20 06:00PM  
Dec-31-19 09:39AM  
Dec-30-19 09:44AM  
Dec-27-19 04:36PM  
02:53PM  
02:14PM  
10:33AM  
08:46AM  
08:02AM  
07:59AM  
05:47AM  
Dec-26-19 04:15PM  
Dec-17-19 07:30AM  
Dec-12-19 03:42PM  
01:12PM  
Dec-10-19 09:00AM  
08:27AM  
Dec-09-19 09:00AM  
Dec-06-19 04:30PM  
Nov-17-19 07:14AM  
Nov-11-19 07:30AM  
Nov-07-19 07:15PM  
04:01PM  
Nov-04-19 07:48AM  
Nov-01-19 04:40PM  
Oct-31-19 04:30PM  
02:20PM  
07:30AM  
Oct-14-19 07:00AM  
12:17AM  
Oct-13-19 04:33PM  
Oct-11-19 08:56AM  
Oct-04-19 04:30PM  
08:40AM  
Oct-02-19 09:00AM  
Sep-30-19 09:04AM  
Sep-23-19 09:00AM  
Sep-18-19 09:31AM  
Sep-10-19 07:36AM  
Sep-09-19 04:01PM  
Sep-06-19 04:30PM  
Sep-04-19 09:55AM  
08:23AM  
Sep-03-19 02:21PM  
Aug-28-19 04:30PM  
Aug-10-19 12:01PM  
Aug-07-19 05:45PM  
04:26PM  
Aug-06-19 06:35PM  
04:01PM  
Aug-05-19 08:53AM  
Aug-02-19 04:30PM  
Jul-30-19 04:30PM  
10:38AM  
Jul-15-19 07:30AM  
Jul-05-19 06:47AM  
Jul-03-19 04:30PM  
Jun-24-19 01:28PM  
Jun-20-19 09:00AM  
Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201 a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MILINAZZO ALANDirectorJul 09Option Exercise2.2018,45040,50022,950Jul 10 04:06 PM
Stejbach MarkDirectorMay 26Buy9.752,05119,9972,051May 27 04:14 PM
Clayman Michael D.President and CEOMay 26Buy9.7510,25699,996346,605May 27 04:11 PM
Arkowitz DavidChief Financial OfficerMay 07Sale10.882,41326,253117,068May 11 04:11 PM
MAHAFFY PATRICK JDirectorAug 29Option Exercise0.1630,8244,93230,824Aug 29 04:46 PM
Willwerth ChristinaChief Strategy OfficerAug 13Option Exercise0.168,7501,40067,169Aug 14 04:06 PM
Clayman Michael D.President and CEOAug 08Buy10.852,31725,13672,249Aug 08 04:38 PM
COLELLA SAMUEL DDirectorAug 08Buy10.742,00021,48045,333Aug 09 04:05 PM